Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Neoplasms of the CNS

  Free Subscription


Articles published in Int J Cancer

Retrieve available abstracts of 33 articles:
HTML format
Text format



Single Articles


    August 2018
  1. OSTROM QT, Kinnersley B, Armstrong G, Rice T, et al
    Age-specific genome-wide association study in glioblastoma identifies increased proportion of 'lower grade glioma'-like features associated with younger age.
    Int J Cancer. 2018 Aug 27. doi: 10.1002/ijc.31759.
    PubMed     Text format     Abstract available


  2. SELIGER C, Luber C, Gerken M, Schaertl J, et al
    Use of metformin and survival of patients with high-grade glioma.
    Int J Cancer. 2018 Aug 9. doi: 10.1002/ijc.31783.
    PubMed     Text format     Abstract available


    June 2018
  3. FERGUSON SD, Zheng S, Xiu J, Zhou S, et al
    Profiles of Brain Metastases: Prioritization of Therapeutic Targets.
    Int J Cancer. 2018 Jun 19. doi: 10.1002/ijc.31624.
    PubMed     Text format     Abstract available


    March 2018
  4. WIRTHSCHAFT P, Bode J, Simon AEM, Hoffmann E, et al
    A PRDX1-p38alpha heterodimer amplifies MET-driven invasion of IDH-wildtype and IDH-mutant gliomas.
    Int J Cancer. 2018 Mar 26. doi: 10.1002/ijc.31404.
    PubMed     Text format     Abstract available


    February 2018
  5. ZHANG G, Chen L, Khan AA, Li B, et al
    miRNA-124-3p/neuropilin-1(NRP-1) axis plays an important role in mediating glioblastoma growth and angiogenesis.
    Int J Cancer. 2018 Feb 19. doi: 10.1002/ijc.31329.
    PubMed     Text format     Abstract available


  6. ERDMANN F, Winther JF, Dalton SO, Zeeb H, et al
    Survival from tumours of the central nervous system in Danish children: Is survival related to family circumstances?
    Int J Cancer. 2018;142:671-680.
    PubMed     Text format     Abstract available


  7. LI X, Wang Y, Wang J, Zhang T, et al
    Enhanced efficacy of AZD3759 and radiation on brain metastasis from EGFR mutant non-small cell lung cancer.
    Int J Cancer. 2018 Feb 12. doi: 10.1002/ijc.31303.
    PubMed     Text format     Abstract available


  8. LAI M, Vassallo I, Lanz B, Poitry-Yamate C, et al
    In vivo characterization of brain metabolism by (1) H MRS, (13) C MRS and (18) FDG PET reveals significant glucose oxidation of invasively growing glioma cells.
    Int J Cancer. 2018 Feb 8. doi: 10.1002/ijc.31299.
    PubMed     Text format     Abstract available


    January 2018
  9. CHEN Y, Zhao F, Cui D, Jiang R, et al
    HOXD-AS1/miR-130a sponge regulates glioma development by targeting E2F8.
    Int J Cancer. 2018 Jan 17. doi: 10.1002/ijc.31262.
    PubMed     Text format     Abstract available


  10. BURLEY TA, Maczynska J, Shah A, Szopa W, et al
    Near-Infrared Photoimmunotherapy Targeting EGFR - Shedding New Light on Glioblastoma Treatment.
    Int J Cancer. 2018 Jan 5. doi: 10.1002/ijc.31246.
    PubMed     Text format     Abstract available


    December 2017
  11. AGRAWAL R, Garg A, Malgulwar PB, Sharma V, et al
    P53 and miR-210 regulated NeuroD2, a neuronal basic helix-loop-helix transcription factor, is downregulated in glioblastoma patients and functions as a tumor suppressor under hypoxic microenvironment.
    Int J Cancer. 2017 Dec 11. doi: 10.1002/ijc.31209.
    PubMed     Text format     Abstract available


  12. DROOP A, Bruns A, Tanner G, Rippaus N, et al
    How to Analyse The Spatiotemporal Tumour Samples Needed To Investigate Cancer Evolution: A Case Study using Paired Primary and Recurrent Glioblastoma.
    Int J Cancer. 2017 Dec 1. doi: 10.1002/ijc.31184.
    PubMed     Text format     Abstract available


    November 2017
  13. KOMURO A, Raja E, Iwata C, Soda M, et al
    Identification of a novel fusion gene HMGA2-EGFR in glioblastoma.
    Int J Cancer. 2017 Nov 29. doi: 10.1002/ijc.31179.
    PubMed     Text format     Abstract available


  14. PIEL C, Pouchieu C, Tual S, Migault L, et al
    Central nervous system tumors and agricultural exposures in the prospective cohort AGRICAN.
    Int J Cancer. 2017;141:1771-1782.
    PubMed     Text format     Abstract available


    October 2017
  15. KOSTOPOULOU ON, Mohammad AA, Bartek J Jr, Winter J, et al
    Glucocorticoids promote a glioma stem cell-like phenotype and resistance to chemotherapy in human glioblastoma primary cells: Biological and prognostic significance.
    Int J Cancer. 2017 Oct 25. doi: 10.1002/ijc.31132.
    PubMed     Text format     Abstract available


  16. CAO M, Mao J, Duan X, Lu L, et al
    In vivo tracking of the tropism of mesenchymal stem cells to malignant gliomas using reporter gene-based MR imaging.
    Int J Cancer. 2017 Oct 19. doi: 10.1002/ijc.31113.
    PubMed     Text format     Abstract available


  17. SRIVASTAVA C, Irshad K, Dikshit B, Chattopadhyay P, et al
    FAT1 modulates EMT and stemness genes expression in hypoxic glioblastoma.
    Int J Cancer. 2017 Oct 9. doi: 10.1002/ijc.31092.
    PubMed     Text format     Abstract available


  18. CONRAD C, Gotte M, Schlomann U, Roessler M, et al
    ADAM8 expression in breast cancer derived metastases: Functional implications on MMP-9 expression and transendothelial migration in breast cancer cells.
    Int J Cancer. 2017 Oct 7. doi: 10.1002/ijc.31090.
    PubMed     Text format     Abstract available


  19. GE H, Mu L, Jin L, Yang C, et al
    Tumor associated CD70 expression is involved in promoting tumor migration and macrophage infiltration in GBM.
    Int J Cancer. 2017;141:1434-1444.
    PubMed     Text format     Abstract available


    September 2017
  20. VIDART D'EGURBIDE BAGAZGOITIA , Bailey HD, Orsi L, Lacour B, et al
    Maternal residential pesticide use during pregnancy and risk of malignant childhood brain tumors: A pooled analysis of the ESCALE and ESTELLE studies (SFCE).
    Int J Cancer. 2017 Sep 26. doi: 10.1002/ijc.31073.
    PubMed     Text format     Abstract available


  21. CIAGLIA E, Laezza C, Abate M, Pisanti S, et al
    Recognition by Natural Killer cells of N6 -isopentenyladenosine-treated human glioma cell lines.
    Int J Cancer. 2017 Sep 7. doi: 10.1002/ijc.31036.
    PubMed     Text format     Abstract available


    August 2017
  22. ESAKI S, Nigim F, Moon E, Luk S, et al
    Blockade of transforming growth factor-beta signaling enhances oncolytic herpes simplex virus efficacy in patient-derived recurrent glioblastoma models.
    Int J Cancer. 2017 Aug 12. doi: 10.1002/ijc.30929.
    PubMed     Text format     Abstract available


    July 2017
  23. YANG J, Liu R, Deng Y, Qian J, et al
    MiR-15a/16 deficiency enhances anti-tumor immunity of glioma-infiltrating CD8+ T cells through targeting mTOR.
    Int J Cancer. 2017 Jul 31. doi: 10.1002/ijc.30912.
    PubMed     Text format     Abstract available


  24. BAYSAN M, Woolard K, Cam MC, Zhang W, et al
    Detailed Longitudinal Sampling of Glioma Stem Cells In Situ Reveals Chr7 Gain and Chr10 Loss As Repeated Events in Primary Tumor Formation and Recurrence.
    Int J Cancer. 2017 Jul 14. doi: 10.1002/ijc.30887.
    PubMed     Text format     Abstract available


  25. DEJAEGHER J, Verschuere T, Vercalsteren E, Boon L, et al
    Characterization of PD-1 upregulation on tumor-infiltrating lymphocytes in human and murine gliomas and preclinical therapeutic blockade.
    Int J Cancer. 2017 Jul 6. doi: 10.1002/ijc.30877.
    PubMed     Text format     Abstract available


    May 2017
  26. JAHAN N, Lee JM, Shah K, Wakimoto H, et al
    Therapeutic targeting of chemoresistant and recurrent glioblastoma stem cells with a proapoptotic variant of oncolytic herpes simplex virus.
    Int J Cancer. 2017 May 31. doi: 10.1002/ijc.30811.
    PubMed     Text format     Abstract available


    April 2017
  27. MURRAY MJ, Bailey S, Heinemann K, Mann J, et al
    Treatment and outcomes of UK and German patients with relapsed intracranial germ cell tumors following uniform first-line therapy.
    Int J Cancer. 2017 Apr 30. doi: 10.1002/ijc.30755.
    PubMed     Text format     Abstract available


  28. PEVERELLI E, Giardino E, Treppiedi D, Meregalli M, et al
    Dopamine receptor type 2 (DRD2) and somatostatin receptor type 2 (SSTR2) agonists are effective in inhibiting proliferation of progenitor/stem-like cells isolated from nonfunctioning pituitary tumors.
    Int J Cancer. 2017;140:1870-1880.
    PubMed     Text format     Abstract available


    March 2017
  29. QIAN Z, Ren L, Wu D, Yang X, et al
    Overexpression of FoxO3a is associated with glioblastoma progression and predicts poor patient prognosis.
    Int J Cancer. 2017 Mar 14. doi: 10.1002/ijc.30690.
    PubMed     Text format     Abstract available


    February 2017
  30. CIAGLIA E, Abate M, Laezza C, Pisanti S, et al
    Antiglioma effects of N6-isopentenyladenosine, an endogenous isoprenoid end product, through the downregulation of epidermal growth factor receptor.
    Int J Cancer. 2017;140:959-972.
    PubMed     Text format     Abstract available


    January 2017
  31. BAILEY HD, Rios P, Lacour B, Guerrini-Rousseau L, et al
    Factors related to pregnancy and birth and the risk of childhood brain tumours: The ESTELLE and ESCALE studies (SFCE, France).
    Int J Cancer. 2017 Jan 5. doi: 10.1002/ijc.30597.
    PubMed     Text format     Abstract available


    September 2016
  32. WANG J, Voellger B, Benzel J, Schlomann U, et al
    Metalloproteinases ADAM12 and MMP-14 are associated with cavernous sinus invasion in pituitary adenomas.
    Int J Cancer. 2016;139:1327-39.
    PubMed     Text format     Abstract available


    April 2016
  33. SMALLEY KS, Fedorenko IV, Kenchappa R, Sahebjam S, et al
    Managing leptomeningeal melanoma metastases in the era of immune and targeted therapy.
    Int J Cancer. 2016 Apr 15. doi: 10.1002/ijc.30147.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Neoplasms of the CNS is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: